# A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

> **NCT02298192** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 420 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin degludec/liraglutide

## Key facts

- **NCT ID:** NCT02298192
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-21
- **Primary completion:** 2015-12-23
- **Final completion:** 2015-12-23
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02298192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02298192, "A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02298192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*